SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeti Read more

TEVA Shares Rise on Broad Support for Opioids Settlement

03:03pm, Tuesday, 10'th Jan 2023 Zacks Investment Research

With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement. Read more

Penny Stocks To Buy Now? 6 To Watch With Big News Today

02:33pm, Monday, 19'th Dec 2022 PennyStocks

Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? 6 To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com Read more

After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB)

02:35pm, Wednesday, 09'th Nov 2022 Zacks Investment Research

The heavy selling pressure might have exhausted for Assembly Biosciences (ASMB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree Read more

NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82%

02:10pm, Monday, 24'th Oct 2022 Benzinga

Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday. Mizuho cut the price target f Read more

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022

02:08pm, Monday, 24'th Oct 2022 Benzinga

Upgrades Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter. Read more

Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor

08:05pm, Wednesday, 05'th Oct 2022 GlobeNewswire Inc.

Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of the board Dr. McHutchison will continue to provide strategic counsel as Read more

Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights

08:05pm, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t Read more

Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why

04:00pm, Thursday, 04'th Aug 2022 Zacks Investment Research

Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read more

Best Momentum Stocks to Buy for August 4th

02:00pm, Thursday, 04'th Aug 2022 Zacks Investment Research

PI, INST and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2022. Read more

New Strong Buy Stocks for August 4th

10:27am, Thursday, 04'th Aug 2022 Zacks Investment Research

ARI, CB, PI, ASMB and URI have been added to the Zacks Rank #1 (Strong Buy) List on August 4, 2022. Read more

Assembly Biosciences Announces Program Reprioritization and Organizational Update

08:05pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.

- Discontinues clinical development of vebicorvir, Assembly Bio’s first-generation core inhibitor, based on interim efficacy data from ongoing combination clinical studies Read more

Assembly Biosciences Presents New Data Highlighting Clinical Progress of Core Inhibitor Programs at EASL’s International Liver Congress™ 2022

12:00pm, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.

SOUTH SAN FRANCISCO, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics Read more

Assembly Biosciences to Introduce New Small Molecule Liver-Focused Interferon-α Receptor Agonist Research Program in Webcast on July 26, 2022

12:00pm, Tuesday, 21'st Jun 2022 GlobeNewswire Inc.

SOUTH SAN FRANCISCO, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t Read more

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

08:05pm, Friday, 03'rd Jun 2022 GlobeNewswire Inc.

SOUTH SAN FRANCISCO, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by